MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
enGene Holdings Inc. Common Stock

ENGN

#2490
enGene Holdings Inc. Common Stock
10.1100
+0.20%
Sector:
Base:
Profit Currency:
Daily Range
10.1100
10.1100
Year Range
5.7200
12.2500
Daily Change
+0.20%
Monthly Change
-9.25%
6 month change
+20.36%
Year Change
+20.36%
Previous Close
10.0900
Open
10.1100
Bid
Ask
Low
10.1100
High
10.1100
Volume
9
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. ENGN
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202320242025 TTM

News

Investing Investing
ARGX CRNX BBIO CMPS ENGN
2026.02.10
Top SMID Cap Biotech Stocks to Watch According to Morgan Stanley
TipRanks TipRanks
ENGN OWLT
2026.01.31
3 Best Stocks to Buy Today, 1/30/2026, According to Top Analysts - TipRanks.com
Investing Investing
ENGN
2026.01.30
Jefferies initiates coverage on Engene stock with Buy rating
Seeking Alpha Seeking Alpha
ENGN ENGNW
2026.01.27
enGene: Two Major Catalysts On Deck For 2nd Half Of 2026 (NASDAQ:ENGN)
Investing Investing
ENGN
2026.01.05
Citizens reiterates Market Outperform rating on Engene stock with $21 target
Seeking Alpha Seeking Alpha
ENGN JNJ URGN RLMD IBRX
2025.12.26
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN)
Investing Investing
ENGN
2025.12.23
Engene stock remains a Buy at H.C. Wainwright on NMIBC treatment advantages
Seeking Alpha Seeking Alpha
ENGN IBRX TARA
2025.12.23
CG Oncology Undervalued Going Into A Busy 2026 (NASDAQ:CGON)
Investing Investing
ENGN
2025.12.22
enGene completes enrollment in bladder cancer treatment trial
Investing Investing
ENGN
2025.12.03
H.C. Wainwright maintains Buy rating on Engene stock as detalimogene joins FDA pilot program
Investing Investing
ENGN
2025.12.02
enGene stock rises after FDA selects bladder cancer therapy for CMC pilot program
Investing Investing
ENGN
2025.12.02
FDA selects enGene’s bladder cancer therapy for development program

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd